# TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammatory Bowel Disease

> **NCT07740499** · — · NOT_YET_RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 80 (estimated)

## Conditions studied

- Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis)

## Interventions

- **PROCEDURE:** biological sample collection: an additional volume of peripheral blood (3-10 ml)
- **PROCEDURE:** biological sample collection: small fragment (1-5 mm) of intestinal tissue - residual or leftover material
- **PROCEDURE:** biological sample collection: leftover peripheral blood samples from healthy subjects

## Key facts

- **NCT ID:** NCT07740499
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10
- **Primary completion:** 2029-10
- **Final completion:** 2029-11
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07740499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07740499, "TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammatory Bowel Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07740499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*